Fidelity Select Pharmaceuticals Portfolio (FPHAX) - Health fund with $1.39 Billion in assets. The fund allocates 81.75% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ELI LILLY and CO at 25.18% of total assets. This is followed by NOVO-NORDISK AS CL B ADR (10.79%) and ASTRAZENECA PLC SPONS ADR (11.19%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ELI LILLY and CO | 25.18% | - | - |
| NOVO-NORDISK AS CL B ADR | 10.79% | - | - |
| ASTRAZENECA PLC SPONS ADR | 11.19% | - | - |
| BRISTOL-MYERS SQUIBB CO | 4.96% | - | - |
| UCB SA | 5.01% | - | - |
| GSK PLC SPONS ADR | 10.07% | - | - |
| MERCK and CO INC NEW | 4.59% | - | - |
| GILEAD SCIENCES INC | 4.64% | - | - |
| Fidelity Cash Central Fund | 3.02% | - | - |
| LEGEND BIOTECH CORP SPON ADR | 2.30% | - | - |
| Fidelity Securities Lending Cash Central Fund | 4.26% | - | - |
| ROYALTY PHARMA PLC | 3.27% | - | - |
| ELANCO ANIMAL HEALTH INC | 4.42% | - | - |
| AVIDITY BIOSCIENCES | 3.42% | - | - |
| JOHNSON and JOHNSON | 7.53% | - | - |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 4.93% | - | - |
| ASTRAZENECA PLC | 4.93% | - | - |